203 related articles for article (PubMed ID: 31211692)
41. Hematologically important mutations: Shwachman-Diamond syndrome.
Costa E; Santos R
Blood Cells Mol Dis; 2008; 40(2):183-4. PubMed ID: 17916435
[TBL] [Abstract][Full Text] [Related]
42. Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome.
Kennedy AL; Myers KC; Bowman J; Gibson CJ; Camarda ND; Furutani E; Muscato GM; Klein RH; Ballotti K; Liu S; Harris CE; Galvin A; Malsch M; Dale D; Gansner JM; Nakano TA; Bertuch A; Vlachos A; Lipton JM; Castillo P; Connelly J; Churpek J; Edwards JR; Hijiya N; Ho RH; Hofmann I; Huang JN; Keel S; Lamble A; Lau BW; Norkin M; Stieglitz E; Stock W; Walkovich K; Boettcher S; Brendel C; Fleming MD; Davies SM; Weller EA; Bahl C; Carter SL; Shimamura A; Lindsley RC
Nat Commun; 2021 Feb; 12(1):1334. PubMed ID: 33637765
[TBL] [Abstract][Full Text] [Related]
43. Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34⁺ cells.
Wang X; Cheng Q; Li L; Wang J; Xia L; Xu X; Sun Z
Exp Cell Res; 2012 Feb; 318(3):196-206. PubMed ID: 22100911
[TBL] [Abstract][Full Text] [Related]
44. Hematologic abnormalities in Shwachman Diamond syndrome: lack of genotype-phenotype relationship.
Kuijpers TW; Alders M; Tool AT; Mellink C; Roos D; Hennekam RC
Blood; 2005 Jul; 106(1):356-61. PubMed ID: 15769891
[TBL] [Abstract][Full Text] [Related]
45. Early severe impairment of hematopoietic stem and progenitor cells from the bone marrow caused by CLP sepsis and endotoxemia in a humanized mice model.
Skirecki T; Kawiak J; Machaj E; Pojda Z; Wasilewska D; Czubak J; Hoser G
Stem Cell Res Ther; 2015 Aug; 6(1):142. PubMed ID: 26272069
[TBL] [Abstract][Full Text] [Related]
46. Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage.
Sioud M; Fløisand Y; Forfang L; Lund-Johansen F
J Mol Biol; 2006 Dec; 364(5):945-54. PubMed ID: 17049554
[TBL] [Abstract][Full Text] [Related]
47. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
48. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
[TBL] [Abstract][Full Text] [Related]
49. Endothelial Cells Promote Expansion of Long-Term Engrafting Marrow Hematopoietic Stem and Progenitor Cells in Primates.
Gori JL; Butler JM; Kunar B; Poulos MG; Ginsberg M; Nolan DJ; Norgaard ZK; Adair JE; Rafii S; Kiem HP
Stem Cells Transl Med; 2017 Mar; 6(3):864-876. PubMed ID: 28297579
[TBL] [Abstract][Full Text] [Related]
50. Genetic analysis of Shwachman-Diamond syndrome: phenotypic heterogeneity in patients carrying identical SBDS mutations.
Kawakami T; Mitsui T; Kanai M; Shirahata E; Sendo D; Kanno M; Noro M; Endoh M; Hama A; Tono C; Ito E; Tsuchiya S; Igarashi Y; Abukawa D; Hayasaka K
Tohoku J Exp Med; 2005 Jul; 206(3):253-9. PubMed ID: 15942154
[TBL] [Abstract][Full Text] [Related]
51. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors.
Pellin D; Loperfido M; Baricordi C; Wolock SL; Montepeloso A; Weinberg OK; Biffi A; Klein AM; Biasco L
Nat Commun; 2019 Jun; 10(1):2395. PubMed ID: 31160568
[TBL] [Abstract][Full Text] [Related]
52. Bone marrow angiotensin AT1 receptor regulates differentiation of monocyte lineage progenitors from hematopoietic stem cells.
Tsubakimoto Y; Yamada H; Yokoi H; Kishida S; Takata H; Kawahito H; Matsui A; Urao N; Nozawa Y; Hirai H; Imanishi J; Ashihara E; Maekawa T; Takahashi T; Okigaki M; Matsubara H
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1529-36. PubMed ID: 19628784
[TBL] [Abstract][Full Text] [Related]
53. Shwachman-Diamond syndrome.
Dror Y
Pediatr Blood Cancer; 2005 Dec; 45(7):892-901. PubMed ID: 16047374
[TBL] [Abstract][Full Text] [Related]
54. Hematopoietic abnormalities in mice deficient in gp130-mediated STAT signaling.
Jenkins BJ; Quilici C; Roberts AW; Grail D; Dunn AR; Ernst M
Exp Hematol; 2002 Nov; 30(11):1248-56. PubMed ID: 12423677
[TBL] [Abstract][Full Text] [Related]
55. Signaling via Smad2 and Smad3 is dispensable for adult murine hematopoietic stem cell function in vivo.
Billing M; Rörby E; Dahl M; Blank U; Andradottír S; Ehinger M; Karlsson S
Exp Hematol; 2017 Nov; 55():34-44.e2. PubMed ID: 28666967
[TBL] [Abstract][Full Text] [Related]
56. Differential activation of MAPK signaling pathways by TGF-beta1 forms the molecular mechanism behind its dose-dependent bidirectional effects on hematopoiesis.
Kale VP
Stem Cells Dev; 2004 Feb; 13(1):27-38. PubMed ID: 15068691
[TBL] [Abstract][Full Text] [Related]
57. Dysregulated hematopoiesis caused by mammary cancer is associated with epigenetic changes and hox gene expression in hematopoietic cells.
Sio A; Chehal MK; Tsai K; Fan X; Roberts ME; Nelson BH; Grembecka J; Cierpicki T; Krebs DL; Harder KW
Cancer Res; 2013 Oct; 73(19):5892-904. PubMed ID: 23913828
[TBL] [Abstract][Full Text] [Related]
58. SBDS protein expression patterns in the bone marrow.
Wong TE; Calicchio ML; Fleming MD; Shimamura A; Harris MH
Pediatr Blood Cancer; 2010 Sep; 55(3):546-9. PubMed ID: 20658628
[TBL] [Abstract][Full Text] [Related]
59. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
60. Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease.
Martínez-Jaramillo G; Gómez-Morales E; Sánchez-Valle E; Mayani H
J Hematother Stem Cell Res; 2001 Jun; 10(3):347-54. PubMed ID: 11454310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
